appstore icon
Our storyOur QFAEventsCareers

UTI Healthcare Fund(G)-Direct Plan

Pharma Health Sector
1 Finance Score:46 /100
1 Finance Rank

This fund ranks 8th out of 16 funds in its category.

08
AUM₹ 1,042 Cr
Expense Ratio1.20%

Strengths and Weaknesses

thub-dislike

Low historical risk-adjusted returns as indicated by two distinct financial risk measures.

thub-dislike

Limited ability to outperform the benchmark.

thub-dislike

During periods of market volatility, this fund's risk management strategy falls short of providing adequate protection to investors.

thub-dislike

The expense ratio for the fund is 1.20%, which is higher than the category average of 0.82%.

Who should invest? 

High conviction in sector performance in the near or long-term.

Who should avoid? 

Unwilling to take the risk of investing in a particular sector or theme.

This analysis is updated as on March 2025.

Disclaimer

The Information in the scoring and ranking model is provided solely for general information and educational purposes and shall not constitute any advice or recommendation. Mutual Fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not an indicator of future returns.

Featured List

Optimise your portfolio with mutual fund advisory!

Talk to a financial advisor

Optimise your portfolio with mutual fund advisory!

Talk to a financial advisor

Did you know?

Nearly 60% of mutual fund equity AUM is invested in Nifty 50 stocks. This means a significant portion of your investment may overlap with these stocks, potentially harming your portfolio due to overdiversification.
Investing in a direct plan could potentially yield an additional annual return of around 1%.
Most mutual fund schemes are unable to maintain their top-ranking position in terms of returns from year to year. Therefore, it's not advisable to make investment decisions solely based on past performance.
Opting for passive funds (Index funds) over active funds presents a superior choice. These funds not only come with minimal fees but also demonstrate consistent outperformance, particularly in the large cap category.